NO940590D0 - Transdermal administrering av benzodiazepiner med kort eller mellomlang halveringstid - Google Patents

Transdermal administrering av benzodiazepiner med kort eller mellomlang halveringstid

Info

Publication number
NO940590D0
NO940590D0 NO940590A NO940590A NO940590D0 NO 940590 D0 NO940590 D0 NO 940590D0 NO 940590 A NO940590 A NO 940590A NO 940590 A NO940590 A NO 940590A NO 940590 D0 NO940590 D0 NO 940590D0
Authority
NO
Norway
Prior art keywords
benzodiazepines
lives
short
transdermal administration
medium half
Prior art date
Application number
NO940590A
Other languages
English (en)
Other versions
NO940590L (no
Inventor
Kuldeepak Sharma
Darth M Durbar
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Publication of NO940590D0 publication Critical patent/NO940590D0/no
Publication of NO940590L publication Critical patent/NO940590L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
NO940590A 1991-08-27 1994-02-21 Transdermal administrering av benzodiazepiner med kort eller mellomlang halveringstid NO940590L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/750,571 US5225198A (en) 1991-08-27 1991-08-27 Transdermal administration of short or intermediate half-life benzodiazepines
PCT/US1992/007033 WO1993003694A1 (en) 1991-08-27 1992-08-19 Transdermal administration of short or intermediate half-life benzodiazepines

Publications (2)

Publication Number Publication Date
NO940590D0 true NO940590D0 (no) 1994-02-21
NO940590L NO940590L (no) 1994-02-21

Family

ID=25018394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940590A NO940590L (no) 1991-08-27 1994-02-21 Transdermal administrering av benzodiazepiner med kort eller mellomlang halveringstid

Country Status (10)

Country Link
US (2) US5225198A (no)
EP (1) EP0621769A4 (no)
JP (1) JPH06510049A (no)
AU (1) AU654875B2 (no)
CA (1) CA2115841A1 (no)
FI (1) FI940948A0 (no)
NO (1) NO940590L (no)
NZ (1) NZ244065A (no)
PT (1) PT100815A (no)
WO (1) WO1993003694A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225198A (en) * 1991-08-27 1993-07-06 Cygnus Therapeutic Systems Transdermal administration of short or intermediate half-life benzodiazepines
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
WO1994021262A1 (en) * 1993-03-17 1994-09-29 Alza Corporation Device for the transdermal administration of alprazolam
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation
US5580574A (en) * 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5552153A (en) * 1994-04-28 1996-09-03 Hoffman-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5635203A (en) * 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
JPH11506744A (ja) 1995-06-07 1999-06-15 ノウブン ファーマシューティカルズ インク． 室温で液体である低分子量薬を含む経皮組成物
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6599532B2 (en) * 2000-01-13 2003-07-29 Osmotica Corp. Osmotic device containing alprazolam and an antipsychotic agent
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
EP1258257A3 (de) * 2001-05-15 2003-09-24 IVF Hartmann AG Hautpflegende Klebstoffzusammensetzung
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246980B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
DE60204229T2 (de) * 2002-12-02 2006-02-02 Schwarz Pharma Ag Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
CN100402036C (zh) * 2004-04-26 2008-07-16 袁重华 治疗失眠的涂敷剂
US20070087055A1 (en) * 2005-10-14 2007-04-19 David Jan Directly compressible extended release alprazolam formulation
US8927537B2 (en) * 2007-12-21 2015-01-06 Nuvo Research Inc. Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs
US10449201B2 (en) 2015-08-17 2019-10-22 Alpha To Omega Pharmaceutical Consultants, Inc. Transdermal and/or topical delivery system comprising clobazam

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987052A (en) * 1969-03-17 1976-10-19 The Upjohn Company 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
JPS6133129A (ja) * 1984-07-25 1986-02-17 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
JPS61254519A (ja) * 1985-05-07 1986-11-12 Nitto Electric Ind Co Ltd ゲル状医薬製剤
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
US5225198A (en) * 1991-08-27 1993-07-06 Cygnus Therapeutic Systems Transdermal administration of short or intermediate half-life benzodiazepines

Also Published As

Publication number Publication date
EP0621769A4 (en) 1995-06-07
AU2488092A (en) 1993-03-16
PT100815A (pt) 1993-09-30
FI940948A (fi) 1994-02-28
WO1993003694A1 (en) 1993-03-04
US5225198A (en) 1993-07-06
JPH06510049A (ja) 1994-11-10
NO940590L (no) 1994-02-21
AU654875B2 (en) 1994-11-24
NZ244065A (en) 1995-02-24
US5378473A (en) 1995-01-03
EP0621769A1 (en) 1994-11-02
CA2115841A1 (en) 1993-03-04
FI940948A0 (fi) 1994-02-28

Similar Documents

Publication Publication Date Title
NO940590D0 (no) Transdermal administrering av benzodiazepiner med kort eller mellomlang halveringstid
FI935223A0 (fi) RAKE-mottagare med selektiv kombinering av straolar
LU90829I2 (fr) Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
FI921281A (fi) Tryckkaensliga silikonlimkompositioner utan loesningsmedel eller med hoeghalt av fast substans
PH23495A (en) Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof
NZ220120A (en) Heterocyclic benzamide derivatives and pharmaceutical composistions
NO862651D0 (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
EP0343622A3 (en) Thrust and torque sensitive drill
DE3677672D1 (de) Halbleiterspeicher mit der moeglichkeit der statischen spalten-dekodierung und seitenmodus-adressierung.
DK625087A (da) Heteroaromatiske aminoderivater dsamt laegemidler med indhold af saadanne forbindelser
DE3472958D1 (en) Synthetic analgesic and/or anti-inflammatory derivatives of manoalide
DK263588A (da) Proterinstof med tnf-virkning
DK403885A (da) Bloedgoeringsmiddelholdigt vaskemiddel med forbedret substantivitet
DK254488D0 (da) Azaindol- og indolizinderivater
AU2782592A (en) Thermal enhancement of transdermal drug administration
NO885210L (no) Anvendelse av cellulosederivater i borspylinger.
NO863565D0 (no) Hemming av styreavgivelse i umettede polyesterharpikser.
DE3683478D1 (de) Schutz von pferden gegen streptococcus equi.
DK470886D0 (da) Oxazol- og isoxazolderivater
GB8500337D0 (en) Preventing unauthorised use of video-cassettes
IT1199757B (it) Rilevatore di velocita'e di fase di elica
DK114189A (da) Benzocycloheptenderivater, samt laegemidler med indhold af saadanne forbindelser
DK69387A (da) Cyanoderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne
NO891985D0 (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
PT88444A (pt) N-<substituted alkylidene>-1,2,3,4-tetrahydro-9-acridinamines aprocess for their preparation and their use as medicaments